Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: A systematic review and meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: A systematic review and meta‐analysis of randomized controlled trials

Published:2020-10-09 Issue:1 Volume:38 Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Zhou Y.¹,Chi J.¹,Huang Y.¹,Dong B.¹,Lv W.¹,Wang Y. G.¹^ORCID

Affiliation:

1. Department of Endocrinology Affiliated Hospital of Medical College Qingdao University Qingdao China

Funder

Ministry of Science and Technology of the People's Republic of China

Ministry of Science and Technology

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14411

Reference40 articles.

1. The Global Epidemiology of Diabetes and Kidney Disease

2. Excess Mortality among Persons with Type 2 Diabetes

3. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3–5: A Network Meta-Analysis of Randomised Clinical Trials

4. GLP‐1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta‐analysis including the REWIND and PIONEER 6 trials

5. The renoprotective effects of sodium‐glucose cotransporter 2 inhibitors versus placebo in patients with type 2 diabetes with or without prevalent kidney disease: A systematic review and meta‐analysis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Women's health and kidney protective medications;Current Opinion in Nephrology & Hypertension;2024-05-03

2. Diabetic kidney disease in type 1 diabetes: challenges and differences from type 2 diabetes;Metabolism;2024-02

3. Underlying Mechanisms and Treatment of Hypertension in Glomerular Diseases;Current Hypertension Reports;2023-11-20

4. Early diabetic kidney disease: Focus on the glycocalyx;World Journal of Diabetes;2023-05-15

5. Efficacy and safety of drugs for people with type 2 diabetes mellitus and chronic kidney disease on kidney and cardiovascular outcomes: A systematic review and network meta-analysis of randomized controlled trials;Diabetes Research and Clinical Practice;2023-04